Skip to main content

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX) and Steris (STE)

Tipranks - Tue Jan 27, 5:04AM CST

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDXResearch Report) and Steris (STEResearch Report).

Claim 50% Off TipRanks Premium

TransMedics Group (TMDX)

In a report released today, Thomas Stephan from Stifel Nicolaus maintained a Hold rating on TransMedics Group, with a price target of $115.00. The company’s shares closed last Friday at $135.30.

According to TipRanks.com, Stephan is a 4-star analyst with an average return of 9.6% and a 40.3% success rate. Stephan covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Alphatec Holdings, and Globus Medical. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for TransMedics Group with a $147.80 average price target.

See today’s best-performing stocks on TipRanks >>

Steris (STE)

In a report released yesterday, Brett Fishbin from KeyBanc maintained a Buy rating on Steris, with a price target of $291.00. The company’s shares closed last Friday at $259.52.

According to TipRanks.com, Fishbin is a 1-star analyst with an average return of -5.3% and a 50.0% success rate. Fishbin covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Solventum Corporation, and Lemaitre Vascular. ;'>

Steris has an analyst consensus of Moderate Buy, with a price target consensus of $291.00.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.